When all parameters (gender, age, RRT duration, CAD, diabetic nephropathy, and BMI) that were applied in the logistic regression analyses in our other evaluations were used in the atherogenic subgroup to compare the adropin concentration between the CC genotype and the T allele patients, the P-value reached significance (P = 0.040), indicating greater adropin production in the CC subjects also under atherogenic conditions. Here, ENHO is linked to diabetic kidney disease.